Feb. 15. 2023
Osaka, Japan – February 15, 2023 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) received approvals by the Ministry of Health, Labour and Welfare for three generic drugs with 10 strengths. The three compounds marked with an asterisk below are approved for the first time as generics.
The list of approved products
1. Azilsartan Tablets, OD Tablets
| Generic name | Azilsartan* |
|---|---|
| Strengths | Tablets: 10mg, 20mg, 40mg OD Tablets: 10mg, 20mg, 40mg |
| Brand products | AZILVA® Tablets 10mg, 20mg, 40mg |
2. Zinc Acetate Tablets
| Generic name | Zinc Acetate Hydrate* |
|---|---|
| Strengths | 25mg, 50mg |
| Brand products | NOBELZIN® Tablets 25mg, 50mg |
3. Lenalidomide Capsules
| Generic name | Lenalidomide* |
|---|---|
| Strengths | 2.5mg, 5mg |
| Brand products | Revlimid® Capsules 2.5mg, 5mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.